Literature DB >> 18569460

NKG2D contributes to efficient clearance of picornavirus from the acutely infected murine brain.

Chandra Deb1, Charles L Howe.   

Abstract

Activated murine cytotoxic T cells express the NKG2D natural cytotoxicity receptor. This receptor recognizes major histocompatibility complex (MHC) class I-like molecules expressed on the surface of infected cells and serves to augment T cell-mediated cytotoxicity. The role of NKG2D-mediated augmentation in the clearance of central nervous system viral infections has not been explored. Using the Theiler's murine encephalomyelitis virus model, the authors found that NKG2D-positive CD8+ cytotoxic T cells enter the brain, that NKG2D ligands are expressed in the brain during acute infection, and that interruption of NKG2D ligand recognition via treatment with a function-blocking antibody attenuates the efficacy of viral clearance from the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18569460      PMCID: PMC3181148          DOI: 10.1080/13550280802105002

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  25 in total

Review 1.  Roles of the NKG2D immunoreceptor and its ligands.

Authors:  David H Raulet
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

2.  Impairment of NK cell function by NKG2D modulation in NOD mice.

Authors:  Kouetsu Ogasawara; Jessica A Hamerman; Honor Hsin; Shunsuke Chikuma; Helene Bour-Jordan; Taian Chen; Thomas Pertel; Claude Carnaud; Jeffrey A Bluestone; Lewis L Lanier
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

3.  Anatomical and cellular requirements for the activation and migration of virus-specific CD8+ T cells to the brain during Theiler's virus infection.

Authors:  Yanice V Mendez-Fernandez; Michael J Hansen; Moses Rodriguez; Larry R Pease
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination.

Authors:  K D Pavelko; B G van Engelen; M Rodriguez
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

5.  Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.

Authors:  Milena Hasan; Astrid Krmpotic; Zsolt Ruzsics; Ivan Bubic; Tihana Lenac; Anne Halenius; Andrea Loewendorf; Martin Messerle; Hartmut Hengel; Stipan Jonjic; Ulrich H Koszinowski
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D.

Authors:  Akio Takada; Shigeru Yoshida; Mizuho Kajikawa; Yukiko Miyatake; Utano Tomaru; Masaharu Sakai; Hitoshi Chiba; Katsumi Maenaka; Daisuke Kohda; Kazunori Fugo; Masanori Kasahara
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

7.  Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide.

Authors:  Yanice V Mendez-Fernandez; Aaron J Johnson; Moses Rodriguez; Larry R Pease
Journal:  Eur J Immunol       Date:  2003-09       Impact factor: 5.532

8.  Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virus.

Authors:  Y Wada; R S Fujinami
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

9.  Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody.

Authors:  Charles L Howe; Allan J Bieber; Arthur E Warrington; Larry R Pease; Moses Rodriguez
Journal:  Neurobiol Dis       Date:  2004-02       Impact factor: 5.996

10.  The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.

Authors:  Melissa B Lodoen; Gerardo Abenes; Sean Umamoto; Jeffrey P Houchins; Fenyong Liu; Lewis L Lanier
Journal:  J Exp Med       Date:  2004-10-11       Impact factor: 14.307

View more
  8 in total

Review 1.  Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy.

Authors:  Kushal Prajapati; Cynthia Perez; Lourdes Beatriz Plaza Rojas; Brianna Burke; Jose A Guevara-Patino
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

2.  Isolation of brain-infiltrating leukocytes.

Authors:  Reghann G LaFrance-Corey; Charles L Howe
Journal:  J Vis Exp       Date:  2011-06-13       Impact factor: 1.355

3.  Functional characterization of mouse spinal cord infiltrating CD8+ lymphocytes.

Authors:  Chandra Deb; Charles L Howe
Journal:  J Neuroimmunol       Date:  2009-07-10       Impact factor: 3.478

Review 4.  Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection.

Authors:  Wolfgang Löscher; Charles L Howe
Journal:  Front Mol Neurosci       Date:  2022-05-09       Impact factor: 6.261

5.  Demyelinated axons and motor function are protected by genetic deletion of perforin in a mouse model of multiple sclerosis.

Authors:  Chandra Deb; Reghann G Lafrance-Corey; Laurie Zoecklein; Louisa Papke; Moses Rodriguez; Charles L Howe
Journal:  J Neuropathol Exp Neurol       Date:  2009-09       Impact factor: 3.685

6.  Phosphatidylinositol 3-Kinase γ is required for the development of experimental cerebral malaria.

Authors:  Norinne Lacerda-Queiroz; Fatima Brant; David Henrique Rodrigues; Juliana Priscila Vago; Milene Alvarenga Rachid; Lirlândia Pires Sousa; Mauro Martins Teixeira; Antonio Lucio Teixeira
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

7.  Inflammatory monocytes and microglia play independent roles in inflammatory ictogenesis.

Authors:  Charles L Howe; Reghann G LaFrance-Corey; Brittany L Overlee; Renee K Johnson; Benjamin D S Clarkson; Emma N Goddery
Journal:  J Neuroinflammation       Date:  2022-01-29       Impact factor: 8.322

8.  Hippocampal protection in mice with an attenuated inflammatory monocyte response to acute CNS picornavirus infection.

Authors:  Charles L Howe; Reghann G Lafrance-Corey; Rhianna S Sundsbak; Brian M Sauer; Stephanie J Lafrance; Eric J Buenz; William F Schmalstieg
Journal:  Sci Rep       Date:  2012-07-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.